Skip to Content

'
Christina A. Meyers

Present Title & Affiliation

Primary Appointment

Professor, Dept. of Neuro-Oncology/Section of Neuropsychology, Division of Cancer Medicine, UT M.D. Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Psychiatry and Behavioral Sciences, The University of Texas Medical School, Houston, TX
Professor, Department of Psychology, University of Houston, Houston, TX
Professor, Department of Symptom Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1982 University of Houston, Houston, TX, PHD, Clinical Neuropsychology
1977 Portland State University, Portland, OR, MS, Psychology
1975 Portland State University, Portland, OR, BS, Biology and Psychology

Postgraduate Training

1/1984-11/1984 Postdoctoral Training, Blue Bird Circle Clinic for Pediatric Neurology, Baylor College of Medicine, Houston, TX
1982-1984 Director of Neuropsychological Assessment, Medical Center Del Oro Hospital, Houston, TX
1978-1982 Predoctoral Internship, UT Medical Branch, Galveston, TX

Board Certifications

6/1996 American Board of Professional Psychology

Selected Publications

Peer-Reviewed Original Research Articles
1. Dickinson MD, Barr CD, Hiscock M, Meyers CA. Cognitive effects of pegylated interferon in individuals with primary brain tumors. J Neurooncol, 5/31/2009. e-Pub 5/31/2009. PMID: 19484406.
2. Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. Int J Radiat Oncol Biol Phys 73(4):1069-76, 3/15/2009. e-Pub 10/30/2008. PMID: 18977094.
3. Groves MD, Puduvalli VK, Gilbert MR, Levin VA, Conrad CA, Liu VH, Hunter K, Meyers CA, Hess KR, Yung WK. Two Phase II Trials of Temozolomide with Interferon-a2b (Pegylated and non-pegylated) in Patients with Recurrent Glioblastoma Multiforme. British Journal of Cancer 101(4):615-620, 2009. PMID: 19672263.
4. Meyers CA, Lamborn KR, Prados MD. In reference to lamborn et Al. (Neuro-oncology. 2008;10:162-170). Neuro Oncol 10(6):1171-2, 12/2008. e-Pub 8/25/2008. PMCID: PMC2719004.
5. Friedman MA, Meyers CA, Sawaya R. Neuropsychological effects of third ventricle tumor surgery. Neurosurgery 62(6 Suppl 3):1093-100, 6/2008. PMID: 18695530.
6. Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 18(2):121-31, 6/2008. e-Pub 4/16/2008. PMID: 18415683.
7. Grosshans DR, Meyers CA, Allen PK, Davenport SD, Komaki R. Neurocognitive function in patients with small cell lung cancer: Effect of prophylactic cranial irradiation. Cancer 112(112):589-595, 2/1/2008. PMID: 18098269.
8. Chang EL, Wefel JS, Maor MH, Hassenbusch SJ, 3rd, Mahajan A, Lang FF, Woo SY, Mathews LA, Allen PK, Shiu AS, Meyers CA. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 60(2):277-83; discussion 283-4, 2007. PMID: 17290178.
9. Mittendorf EA, Wefel JS, Meyers CA, Doherty D, Shapiro SE, Lee JE, Evans DB, Perrier ND. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Practice 13(4):338-44, Jul-Aug, 2007. PMID: 17669708.
10. Pavol M,Hiscock M,Massman P,Moore B,Foorman B,Meyers CA. Neuropsychological function in adults with Von Recklinghausen's neurofibromatosis. Developmental Neuropsychology 29:509-26, 2006.
11. Rivera E,Meyers C,Groves M,Valero V,Francis D,Arun B,Broglio K,Yin G,Hortobafyi GN,Buchholz T. Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer 107(6):1348-54, 2006. PMID: 16909414.
12. Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104(4):788-93, 2005. PMID: 15973668.
13. Puduvalli VK, Yung WK, Hess KR, Kuhn JG, Groves MD, Levin VA, Zwiebel J, Chang SM, Cloughesy TF, Junck L, Wen P, Lieberman F, Conrad CA, Gilbert MR, Meyers CA, Liu V, Mehta MP, Nicholas MK, Prados M. Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study. J Clin Oncol 22(21):4282-9, 11/2004. PMID: 15514370.
14. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma?: a prologue. Cancer 101(3):466-75, 8/2004. PMID: 15274059.
15. Lee BN, Dantzer R, Langley KE, Bennett GJ, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Cleeland CS. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11(5):279-92, 2004. PMID: 15316238.
16. Tran HT, Blumenschein GR, Jr, Lu C, Meyers CA, Papadimitrakopoulou V, Fossella FV, Zinner R, Madden T, Smythe LG, Puduvalli VK, Munden R, Truong M, Herbst RS. Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors. Cancer Chemother Pharmacol 54(4):308-14, 2004. e-Pub 6/4/2004. PMID: 15184994.
17. Scheibel RS, Valentine AD, O’Brien S, Meyers CA. Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. Journal of Neuropsychiatry and Clinical Neurosciences 16(2):185-191, 2004. PMID: 15260370.
18. Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER,. Depression in patients with high- grade glioma: results of the Glioma Outcomes Project. Neurosurgery 54(2):358-367, 2004. PMID: 14744282.
19. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22(1):157-65, 2004. PMID: 14701778.
20. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100(11):2292-9, 2004. PMID: 15160331.
21. Meyers CA, Hess KR. Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression. Neuro Oncol 5(2):89-95, 2003. PMCID: PMC1920671.

Invited Articles
1. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. The Oncologist 13((12)):1285-1295, 2008. e-Pub 11/19/2008. PMID: 19019972.
2. Meyers CA. How chemotherapy damages the central nervous system. J Biol 7(11):11, 2008. e-Pub 4/22/2008. PMCID: PMC2397491.

Books (edited and written)
1. Meyers CA, Perry J. Cognition and Cancer. Cambridge University Press, in progress: Cambridge, 2008.

Grant & Contract Support

Title: SPORE in Brain Cancer - Genetic Modulation of Cognitive Function and Annual Direct Outcomes in Glioblastoma Patients
Funding Source: NIH/NCI
Role: Co-Program Leader
Principal Investigator: WKA Yung
Duration: 3/1/2008 - 2/28/2013

Last updated: 9/16/2009